1496
S. Piper, N. Risch
LETTER
3-Dimethylamino-4,4-dimethyl-dihydro-furan-2-one
(10a): 1H NMR (200 MHz, CDCl3): d = 1.09 (s, 3 H), 1.13
(s, 3 H), 2.44 (s, 6 H), 2.93 (s, 1 H), (dA = 3.80, dB = 3.88, 2
H, J = 8.9 Hz) ppm. 13C NMR (50 MHz, CDCl3): d = 20.85,
27.09 (q), 40.96 (s), 44.51 (q), 72.72 (d), 78.36 (t), 175.43 (s)
ppm. IR (neat): 2962, 2925, 2362, 2341, 1770, 1736, 1456,
1432, 1261, 1081, 1018, 798 cm–1. MS (80 eV): m/z
(%) = 157 (100) [M]+, 141 (10), 128 (9), 112 (10), 102 (46),
82 (17), 58 (18), 49 (88), 42 (60).
THF (4.0 mmol, 4 mL)12 at 20 °C. After a reaction time of
10 h, the mixture was quenched very slowly with H2O and
HCl (6 N). The aqueous layer was washed with Et2O several
times and basified by the addition of aq sat. NaHCO3
solution and NaOH (2 N) to pH 10–12. The product was
extracted with CH2Cl2, the combined organic layers were
dried (Na2SO4) and the solvent was removed in vacuo.
Analytical data of some representative synthesized
compounds (* minor diastereoisomer):
3-Dibenzylamino-4,4-dimethyl-dihydro-furan-2-one
(10c): 1H NMR (200 MHz, CDCl3): d = 0.66 (s, 3 H), 1.07
(s, 3 H), 3.16–3.29 (m, 5 H), 4.12–4.32 (m, 2 H), 7.12–7.40
(m, 10 H) ppm. 13C NMR (50 MHz, CDCl3): d = 20.80,
24.19 (q), 38.93 (s), 57.70 (t), 66.46 (d), 71.79 (t), 127.96,
129.01, 129.79 (d), 139.27 (s), 170.99 (s) ppm. IR (neat):
2958, 1763, 1736, 1493, 1448, 1365, 1130, 1026, 741, 696
cm–1. MS (80 eV): m/z (%) = 309 (100) [M]+, 281 (12), 253
(49), 217 (62), 195 (20), 105 (10), 91 (42), 65 (5), 53 (3), 41
(5).
3-Dimethylamino-2-methyl-2-phenyl-butane-1,4-diol
(11a): 1H NMR (200 MHz, CDCl3): d = 1.12*, 1.36 (s, 3 H),
2.08*, 2.50 (s, 6 H), 3.02–3.25 (m, 2 H), 3.57–4.11 (m, 3 H),
7.06–7.55 (m, 5 H) ppm. 13C NMR (50 MHz, CDCl3): d =
16.04*, 24.58, 43.19, 44.31* (q), 44.61*, 45.00 (s), 59.96*,
60.59, 73.75*, 74.15 (t), 74.74*, 74.83, 126.11, 126.85*,
127.05, 128.49, 128.96* (d), 144.37*, 145.08 (s) ppm. IR
(neat): 3350, 2947, 2881, 2843, 2252, 1498, 1466, 1444,
1385, 1026, 910, 737, 650 cm–1. MS (70 eV): m/z (%) = 223
(5) [M]+, 192 (88), 176 (11), 162 (87), 147 (39), 118 (74),
115 (76), 102 (67), 88 (94), 70 (96), 58 (95) 44 (97), 28
(100).
4-Piperidin-1-yl-2-oxa-spiro[4.5]decan-3-one (10e): 1H
NMR (200 MHz, CDCl3): d = 0.98–1.55 (m, 16 H), 2.24–
2.45 (m, 2 H), 2.45–2.60 (m, 2 H), 2.74 (s, 1 H), (dA = 3.73,
dB = 3.82, 2 H, J = 9.2 Hz) ppm. 13C NMR (50 MHz,
CDCl3): d = 22.85, 23.06, 24.18, 25.63, 26.84, 29.20, 36.43
(t), 42.76 (s), 53.19 (t), 71.86, 77.28 (d), 175.42 (s) ppm. IR
(KBr): 2931, 2852, 1772, 1450, 1169, 1144, 1099, 1012
cm–1. MS (80 eV): m/z (%) = 237 (100) [M]+, 192 (2), 150
(8), 141 (56), 122 (8), 110 (11), 96 (9), 84 (10), 53 (3), 41 (5).
3-Dimethylamino-4-methyl-4-phenyl-dihydro-furan-2-
one (10f): 1H NMR (200 MHz, CDCl3): d = 1.44, 1.46* (s, 3
H), 2.07, 2.44* (s, 6 H), 3.36, 3.59* (s, 1 H), (dA = 4.19,
dB = 4.62, 2 H, J = 9.2 Hz), (dA = 4.12, dB = 4.24, 2 H,
J = 9.0 Hz, CH2O)*, 7.12–7.43 (m, 5 H) ppm. 13C NMR (50
MHz, CDCl3): d = 22.34*, 29.41, 43.13, 44.93* (q), 46.82,
48.26* (s), 72.14*, 72.76 (d), 76.83*, 77.43 (t), 125.74*,
127.20, 127.43*, 127.55, 128.81, 129.27* (d), 141.48*,
144.84, 174.54*, 174.92 (s) ppm. IR (film): 2974, 2943,
2904, 2877, 2841, 2789, 2254, 1770, 1498, 1446, 1163,
1024, 910, 737, 650 cm–1. MS (80 eV): m/z (%) = 219 (60)
[M]+, 159 (6), 143 (4), 130 (4), 116 (11), 102 (100), 91 (4),
58 (24), 42 (31).
4-Methyl-4-phenyl-3-piperidin-1-yl-dihydro-furan-2-
one; Compound with Methane (10g): 1H NMR (200 MHz,
CDCl3): d = 1.12–1.26 (m, 4 H), 1.43, 1.44* (s, 3 H), 1.47–
1.60 (m, 2 H), 2.12–2.27 (m, 2 H), 2.31–2.49 (m, 2 H), 3.31,
3.53* (s, 1 H), (dA = 4.19, dB = 4.64, 2 H, J = 9.3 Hz),
(dA = 4.18, dB = 4.31, 2 H, J = 9.0 Hz)*, 7.11–7.35 (m, 5 H)
ppm. 13C NMR (50 MHz, CDCl3): d = 22.77*, 29.20 (q),
24.17, 24.47*, 26.71, 27.20* (t), 46.68, 48.01* (s), 51.96,
53.69* (t), 72.87*, 73.78 (d), 76.45*, 77.56 (t), 125.47*,
127.23, 127.35, 128.42, 129.16* (d), 141.43, 145.68*,
174.73*, 175.05 (s) ppm. IR (neat): 2939, 2856, 2252, 1759,
1626, 1446, 1169, 1107, 1024, 910, 737, 650 cm–1. MS (80
eV): m/z (%) = 259 (29) [M]+, 142 (100), 117 (12), 96 (7), 68
(7), 55 (8), 41 (20).
2-Methyl-2-phenyl-3-piperidin-1-yl-butane-1,4-diol
(11b): 1H NMR (200 MHz, CDCl3): d = 1.36 (s, 3 H), 1.41–
1.64 (m, 6 H), 2.11–2.52 (m, 2 H) 2.67–2.84 (m, 2 H), 2.89–
3.01 (m, 2 H), 3.08 (t, 1 H, J = 11.9 Hz), (dA = 3.66,
dB = 4.04, 2 H, J = 9.9 Hz), 7.04–7.26 (m, 5 H) ppm. 13
C
NMR (50 MHz, CDCl3): d = 16.27 (q), 24.64, 27.49 (t),
45.21 (s), 54.86, 60.43, 74.65 (t), 76.60, 126.07, 126.93,
128.89 (d), 144.34 (s) ppm. IR (KBr): 3361, 2937, 2854,
2252, 1468, 1454, 1442, 1039, 1026, 908, 733, 650 cm–1. MS
(70 eV): m/z (%) = 263 (8) [M]+, 232 (87), 210 (33), 201
(40), 142 (92), 128 (92), 118 (87), 112 (100), 98 (91), 84
(91), 69 (71), 55 (90), 41 (98), 28 (73).
2-Benzo[1,3]dioxol-5-ylmethyl-3-dimethylamino-2-
methyl-butane-1,4-diol (11c): 1H NMR (200 MHz,
CDCl3): d = 0.52, 0.88* (s, 3 H), 2.45*, 2.51 (s, 6 H), 2.59–
2.73 (m, 2 H), 3.11–3.57 (m, 3 H), 3.82–4.07 (m, 2 H), 5.83,
5.84* (s, 2 H), 6.44–6.75 (m, 3 H) ppm. 13C NMR (50 MHz,
CDCl3): d = 17.93*, 21.65 (q), 36.30 (t), 41.29*, 41.49 (s),
44.39, 44.68* (q), 59.41*, 59.68, 70.27, 71.37* (t), 72.65*,
75.65 (d), 101.09, 101.23* (t), 108.04, 108.18*, 111.35*,
111.56, 123.97*, 124.08 (d), 131.15*, 131.78, 146.13,
146.39*, 147.51, 147.62* (s) ppm. IR (KBr): 3329, 2945,
2879, 2252, 1504, 1489, 1442, 1248, 1095, 1041, 906, 733,
650 cm–1. MS (80 eV): m/z (%) = 281 (70) [M]+, 249 (5), 134
(6), 113 (1), 98 (7), 88 (100), 58 (31), 44 (4).
2-Benzo[1,3]dioxol-5-ylmethyl-2-methyl-3-piperidin-1-
yl-butane-1,4-diol (11d): 1H NMR (200 MHz, CDCl3): d
= 0.50, 0.87* (s, 3 H), 1.27–1.63 (m, 6 H), 2.24–2.46 (m, 2
H), 2.54–2.78 (m, 2 H), 2.84–3.05 (m, 6 H), 3.08–3.55 (m, 3
H), 3.75–4.07 (m, 2 H), 5.81, 5.82* (s, 2 H), 6.42–6.75 (m,
3 H) ppm. 13C NMR (50 MHz, CDCl3): d = 18.25*, 21.86,
24.65*, 26.04, 27.47 (q), 36.45 (t), 41.36*, 41.55 (s), 44.57*
(t), 53.32*, 54.88 (q), 59.47*, 59.68, 70.38, 71.27*(t),
74.27*, 77.56 (d), 101.06, 101.21* (t), 108.00, 108.15*,
111.35*, 111.55, 123.95* 124.05 (d), 131.27*, 131.86,
146.10, 146.36*, 147.50, 147.60* (s) ppm. IR (film): 3352,
2937, 2854, 2252, 1504, 1489, 1442, 1246, 1097, 1041, 910,
733, 650 cm–1. MS (80 eV): m/z (%) = 321 (12) [M]+, 287
(52), 257 (5), 206 (5), 175 (9), 151 (18), 134 (100), 128 (78),
98 (92), 77 (30), 41 (48).
(12) The hydrochlorides may also be deprotonated with aq sat.
NaHCO3 before reduction. However, the deprotonation with
the reducing agent is useful for small quantity of the b-
formyl-a-aminocarboxylate hydrochlorides.
(13) Reduction with LiAlH4 to Yield a,a-Dialkyl-b-
dialkylamino-butane-1,4-diols 11. To hydrochlorides 7
(1.0 mmol) in anhyd THF (10 mL) was added 1 M LiAlH4 in
Synlett 2004, No. 9, 1489–1496 © Thieme Stuttgart · New York